Patents
Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
09/2002
09/18/2002EP1239949A1 New functionalized polymeric reagents
09/18/2002EP1000052B1 Process for preparing 3-isochromanome
09/18/2002EP0929516B1 Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect
09/18/2002EP0804427B1 Lta4 hydrolase inhibitors
09/18/2002EP0764158B1 Benzopyrans and their use as therapeutic agents
09/18/2002CN1370173A Isomeric fused pyrrolocarbazoles and isoindolones
09/18/2002CN1370156A Benzopyrans and benzothiopyrans as RAR selective retinoid agonists
09/18/2002CN1369487A Process for fractionally extracting natural VE by supercritical CO2 fluid
09/18/2002CN1369486A Biological general flavone prepared from bulbillus and its preparing process
09/18/2002CN1091107C Method for raising natural vitamin E concentrate transparency and fluidity
09/18/2002CN1091106C Supercritical fluid extraction process for extracting concentrated natural vitamin E
09/17/2002US6452023 Condensation of trimethylhydroquinone with phytol and/or isophytol and ethylene carbonate and/or propylene carbonate; acid catalyzed with 12-tungstophosphoric acid, 12-molybdophosphoric acid or 12-tungstosilicic acid
09/17/2002US6452020 Methods of making magenta colorants for ink systems
09/17/2002US6451846 Isocoumarin derivatives inhibiting angiogenesis
09/17/2002US6451776 Water soluble prodrugs of hindered alcohols
09/12/2002WO2002070516A2 Cyclopropaheterocycles as non-nucleoside reverse transcriptase inhibitors
09/12/2002WO2002070507A2 Glycorticoid receptor antagonists for treatment of diabetes
09/12/2002WO2002070506A2 Conversion of cbd to δ8-thc and δ9-thc
09/12/2002WO2002070505A1 Preparation of warfarin sodium from warfarin acid
09/12/2002WO2002070504A1 Preparation of warfarin sodium from warfarin sodium-2-propanol clathrate by solvent expulsion
09/12/2002WO2002070503A1 Process for purification of warfarin acid, warfarin alkali metal salts and corresponding clathrates
09/12/2002WO2002070502A1 Dimeric isoflavones
09/12/2002WO2002069993A1 Pharmaceutical composition made of cannabis extracts
09/12/2002US20020128494 N-Disubstituted carbamoyloxy flavones
09/12/2002US20020128493 Synthetic methods for polyphenols
09/12/2002US20020128294 Nicotine in therapeutic angiogenesis and vasculogenesis
09/12/2002US20020128267 Especially celecoxib, deracoxib, valdecoxib, a benzopyran COX-2 inhibitor, parecoxib, rofecoxib etoricoxib, or a 2-(3,5-difluorophenyl)-3-(4-(methylsulfonyl)phenyl) -substituted cyclopentenone, or pyridazinone
09/12/2002US20020128255 Substituted hydroxyl amine derivatives; inhibitors of beta-secretase, inhibit beta-secretase-mediated cleavage, inhibitors of A beta production, and/or are effective to reduce amyloid beta deposits or plaques
09/12/2002US20020128243 Administering a polycyclic sulfamate ester that is replaced with a sulfate group and incubated with a seroid sulphatase enzyme at 7.4 pH and 37 degrees C to provide a Km value of < 50 micrometers
09/12/2002US20020127428 Organic light emitting displays and new fluorescent compounds
09/12/2002US20020127366 Singly recordable compact disc (CD-R)
09/12/2002US20020127320 Subjecting a 2-hydroxychroman compound and aspartame to a reductive alkylation reaction to produce N-(N-(3-(2-hydroxy-substituted phenyl)propyl)-L- alpha -aspartyl)-L-phenylalanine 1-methyl ester compound
09/12/2002US20020127202 Compounds and compositions for delivering active agents
09/12/2002US20020125463 Naphthopyrans annelated in C5-C6 with a dihydrobenzo-cycloheptatriene-type carbocycle and compositions and matrices containing them
09/12/2002CA2440642A1 Dimeric isoflavones
09/12/2002CA2440070A1 Pharmaceutical composition made of cannabis extracts
09/12/2002CA2439489A1 Preparation of warfarin sodium from warfarin sodium-2-propanol clathrate by solvent expulsion
09/12/2002CA2439488A1 Process for purification of warfarin acid, warfarin alkali metal salts and corresponding clathrates
09/12/2002CA2438407A1 Preparation of warfarin sodium from warfarin acid
09/11/2002EP1239045A1 Process for the manufacture of a vitamin E intermediate
09/11/2002EP1237885A1 Method for preparing dl-alpha-tocopherol with a high yield and high purity
09/11/2002EP1237849A1 Activators of soluble guanylate cyclase
09/11/2002EP0984929B1 Naphthopyran derivatives, compositions and (co)polymer matrices containing the same
09/11/2002EP0668860B1 Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hiv and other retroviruses
09/11/2002CN1368050A Process for preparing VE-succinate injection
09/11/2002CN1090626C Hydroxymethylation of tocopherols
09/10/2002US6448407 Atropisomers of asymmetric xanthene fluorescent dyes and methods of DNA sequencing and fragment analysis
09/10/2002US6448405 Coupling a 2-halo-5-nitrobenzoic acid and a 2-methoxyphenyl boronic acid; cyclizing to a nitrobenzocoumarin; reducing to the amine; converting to a coumarino(3,4-f)quinoline; reduction to a 5h-chromeno(3,4-f)quinoline
09/10/2002US6448288 Cannabinoid drugs
09/10/2002US6448269 Such as 6-(n-(4-(aminoiminomethyl)benzoyl)amino)-3,4-dihydro-4,4-dimethyl-2h-1 -benzopyran-2-yl)acetic acid; inhibiting platelet aggregation or fibrinogen binding or preventing thrombosis
09/06/2002WO2002068405A1 Organic red electroluminescent chromophores, method for the production and use thereof
09/06/2002WO2002067988A2 Use of natural egfr inhibitors to prevent side effects due to retinoid therapy, soaps, and other stimuli that activate the epidermal growth receptor
09/06/2002WO2002026728A3 Antiviral methods and compounds
09/06/2002WO2002022577A3 Hydroxamate derivatives useful as deacetylase inhibitors
09/06/2002WO2001095937A3 Phytoestrogenic isoflavone compositions
09/06/2002WO2001094331A3 Methods for producing amino-substituted chromanes
09/05/2002US20020123630 Substituted benzopyran/quinoline or other heterobicyclic compounds useful for treating anxiety, depression, mania, drug abuse, epilepsy, Parkinson's disease, psychosis, migraine or cerebral ischaemia
09/05/2002US20020123032 Detection of disease related genes
09/04/2002EP1236724A1 NEUTRALIZING AGENT FOR TOXIN OF MICROORGANISM BELONGING TO THE GENUS i CLOSTRIDIUM /i
09/04/2002EP1235823A1 H-annellated benzo f]chromenes
09/04/2002EP1235822A1 Tocotrienols and geranylgeraniol from bixa orellana byproducts
09/04/2002EP1149066A4 Method of preparing alkylated salicylamides
09/04/2002EP1091951B1 Novel polyoxypropylenepolyoxyethylene vitamin e and preparation thereof
09/04/2002EP0915864B1 Gastroprotective flavone/flavanone compounds with therapeutic effect on inflammatory bowel disease
09/04/2002EP0635008B1 Piperazides of substituted phenylalanine derivates as thrombin inhibitors
09/04/2002CN1367171A Extraction method of high-content EGCg catechin
09/04/2002CN1367161A Method for restoring low-grade tea-polyphenol bio-activity
09/04/2002CN1090055C Cloth or cloth-like packing which is subject to low pressure losses and has ordered structure for use in material-exchange columns and rectification method using such packing
09/04/2002CN1090054C Distillation tower using wall-flow-reducing structural filler
09/03/2002US6444860 Naphthopyrans and phenanthropyrans annelated in C5-C6 with a bicyclic group, and compositions and (co) polymer matrices containing them
09/03/2002US6444826 Processes and intermediates for preparing substituted chromanol derivatives
09/03/2002US6444098 Process for the preparation of tocol acylates and tocopherol acylates
09/03/2002CA2128293C Fruit polyphenols and medicinal compositions containing them
08/2002
08/29/2002WO2002066454A1 Chromene derivatives
08/29/2002WO2002066428A2 Non-steroidal estrogen receptor ligands
08/29/2002WO2001094330A3 Methods for producing amino substituted chromanes
08/29/2002US20020120157 Conducted in a polar organic solvent, preferably ethanol, using a volatilizable base, preferably sodium carbonate, at low temperature. Drying the final product is accomplished at low temperature to avoid decomposition
08/29/2002US20020120156 Preparation of warfarin sodium from warfarin sodium-2-propanol clathrate
08/29/2002US20020120155 Process for synthesis of pure warfarin acid, warfarin alkali metal salts and corresponding clathrates
08/29/2002US20020119910 Drug delivery
08/28/2002EP1233956A1 Bryostatin analogues, synthetic methods and uses
08/28/2002EP1233947A1 Preparation of 3-substituted-4-arylquinolin-2-one derivatives
08/28/2002EP1051411B1 Methods for separating a tocol from a tocol-containing mixture
08/28/2002EP1040106B1 Carboxyl substituted chroman derivatives useful as beta 3 adrenoreceptor agonists
08/28/2002EP0869785B1 4-hydroxycoumarin-3-carboxamides for the treatment of non-insulin dependent diabetes mellitus
08/28/2002EP0848696B1 2,4-pentadienoic acid derivatives having retinoid-like biological activity
08/28/2002CN1365977A Production method of (per-rac) alpha tocopherol
08/28/2002CN1365976A Process for extracting medicinal component from pueraria root
08/27/2002US6441200 Method for preparing DL-α-tocopherol with a high yield and high purity
08/27/2002US6441199 Process for the production of α-tocopherol acetate by condensation of trimethylhydroquinone with isophytol with recycling of an acetic catalyst solution
08/27/2002US6441173 Process for preparing indane carboxylate and cyclopentano [6] pyridine derivatives
08/27/2002US6441030 3-phenyl-pyrones
08/27/2002US6440709 Via fermentation broth; useful as amyloid aggregation inhibitor for treatment of alzheimer's
08/22/2002WO2002064581A1 4-aminobenzopyran derivatives
08/22/2002US20020115876 Removal of polar components using lower alkyl alcohol or a water mixture, distilling off the alcohol, adding bleaching earth, followed by filtration, and deodorizing at low temperature
08/22/2002US20020115654 New compounds, their preparation and use
08/22/2002US20020115092 Label for use in nucleotide sequence analysis
08/22/2002US20020115067 Asymmetric benzoxanthene dye labelling reagents
08/22/2002DE10106024A1 Verfahren zur Herstellung von Dronabinol Process for preparing dronabinol
08/21/2002EP1232756A1 Drugs, drinks or foods